Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Shares Issued (2020 - 2022)

Historic Shares Issued for Candel Therapeutics (CADL) over the last 3 years, with Q4 2022 value amounting to $36000.0.

  • Candel Therapeutics' Shares Issued changed N/A to $36000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $64000.0, marking a year-over-year decrease of 9991.03%. This contributed to the annual value of $1.7 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q4 2022, Candel Therapeutics' Shares Issued is $36000.0.
  • Candel Therapeutics' Shares Issued's 5-year high stood at $70.9 million during Q3 2021, with a 5-year trough of $6000.0 in Q1 2022.
  • Its 3-year average for Shares Issued is $10.2 million, with a median of $36000.0 in 2022.
  • The largest annual percentage gain for Candel Therapeutics' Shares Issued in the last 5 years was 9220.78% (2022), contrasted with its biggest fall of 9339.34% (2022).
  • Over the past 3 years, Candel Therapeutics' Shares Issued (Quarter) stood at $29000.0 in 2020, then skyrocketed by 244468.97% to $70.9 million in 2021, then crashed by 99.95% to $36000.0 in 2022.
  • Its last three reported values are $36000.0 in Q4 2022, $22000.0 for Q2 2022, and $6000.0 during Q1 2022.